Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1

被引:8
|
作者
Ali, Marco [1 ,2 ]
Monti, Caterina Beatrice [3 ]
Melazzini, Luca [3 ]
Cardani, Rosanna [4 ]
Fossati, Barbara [5 ,6 ]
Cavalli, Michele [7 ]
Chow, Kelvin [8 ]
Secchi, Francesco [2 ,9 ]
Meola, Giovanni [5 ,6 ,9 ]
Sardanelli, Francesco [2 ,9 ]
机构
[1] CDI Ctr Diagnost Italiano SpA, Unit Diagnost Imaging & Stereotact Radiosurg, Milan, Italy
[2] IRCCS Policlin San Donato, Unit Radiol, San Donato Milanese, Italy
[3] Univ Milan, Dept Biomed Sci Hlth, PhD Course Integrat Biomed Res, Milan, Italy
[4] IRCCS Policlin San Donato, Lab Muscle Histopathol & Mol Biol, San Donato Milanese, Italy
[5] IRCCS Policlin San Donato, Unit Neurol, San Donato Milanese, Italy
[6] Casa di Cura Policlin, Dept Neurorehabil Sci, Milan, Italy
[7] Univ Milan, Postgrad Sch Neurol, Milan, Italy
[8] Siemens Med Solut USA Inc, Chicago, IL USA
[9] Univ Milan, Dept Biomed Sci Hlth, San Donato Milanese, Italy
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
关键词
myotonic dystrophy; cardiac magnetic resonance; myocardial strain imaging; extracellular volume; cardiac fibrosis; RESONANCE FEATURE TRACKING; MUSCULAR-DYSTROPHY; SPECKLE TRACKING; CTG REPEAT; TROPONIN-T; IMPAIRMENT; STRAIN; INVOLVEMENT; SYSTEM;
D O I
10.3389/fneur.2020.00192
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology. Materials and methods: We retrospectively analyzed 9 DM1 patients without apparent cardiac disease who had undergone cardiac magnetic resonance at our center. Patients were age- and sex-matched with healthy controls. The Mann-Whitney U test was used to compare cardiac strain between the two groups. The t-test was used to compare the extracellular volume obtained in DM1 patients with that in healthy subject. Spearman's rho was used for studying the associations among imaging parameters. Results: Global cardiac strain (median -19.1%; IQR -20.5%, -16.5%) in DM1 patients was lower (p = 0.011) than that in controls (median-21.7%; IQR-22.7%,-21.3%). Global extracellular volume in DM1 patients (median 32.3%; IQR 29.3%,36.8%) was significantly (p = 0.008) higher than that reported in literature in healthy subjects (median 25.6%; IQR 19.9%,31.9%). Global cardiac strain showed a strong, positive correlation with septal strain (rho = 0.767, p = 0.016) and with both global (rho = 0.733 p = 0.025) and septal extracellular volume (rho = 0.767, p = 0.016). Discussion: The increase in cardiac extracellular volume and decrease in strain are signs of early cardiac pathology in DM1. Physicians dealing with DM1 may take into consideration cardiac magnetic resonance as a screening tool to identify early cardiac involvement in this condition.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy
    Abati, Elena
    Alberti, Claudia
    Tambe, Valentina
    Esseridou, Anastasia
    Comi, Giacomo Pietro
    Corti, Stefania
    Meola, Giovanni
    Secchi, Francesco
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [2] Cardiac manifestations of myotonic dystrophy type 1
    Petri, Helle
    Vissing, John
    Witting, Nanna
    Bundgaard, Henning
    Kober, Lars
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 160 (02) : 82 - 88
  • [3] Cardiac Pathology in Myotonic Dystrophy Type 1
    Mahadevan, Mani S.
    Yadava, Ramesh S.
    Mandal, Mahua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [4] Dyspnea assessment in myotonic dystrophy type 1
    Delbarrea, B.
    Rapin, A.
    Boyer, F. C.
    Thierry, A.
    Perotin, J. M.
    Dury, S.
    Dumazet, A.
    Hagenburg, J.
    Perdu, D.
    Deslee, G.
    Launois, C.
    NEUROMUSCULAR DISORDERS, 2023, 33 (02) : 187 - 195
  • [5] TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
    Bose, Francesca
    Renna, Laura Valentina
    Fossati, Barbara
    Arpa, Giovanni
    Labate, Valentina
    Milani, Valentina
    Botta, Annalisa
    Micaglio, Emanuele
    Meola, Giovanni
    Cardani, Rosanna
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [6] Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy
    Leali, Marco
    Aimo, Alberto
    Ricci, Giulia
    Torri, Francesca
    Todiere, Giancarlo
    Vergaro, Giuseppe
    Grigoratos, Chrysanthos
    Giannoni, Alberto
    Aquaro, Giovanni Donato
    Siciliano, Gabriele
    Emdin, Michele
    Passino, Claudio
    Barison, Andrea
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (06) : 340 - 347
  • [7] Cognitive assessment in patients with myotonic dystrophy type 2
    Peric, Stojan
    Gunjic, Ilija
    Delic, Neda
    Tamas, Olivera Stojiljkovic
    Salak-Djokic, Biljana
    Pesovic, Jovan
    Djordjevic, Ivana Petrovic
    Ivanovic, Vukan
    Savic-Pavicevic, Dusanka
    Meola, Giovanni
    Rakocevic-Stojanovic, Vidosava
    NEUROMUSCULAR DISORDERS, 2022, 32 (09) : 743 - 748
  • [8] Body composition and clinical outcome measures in patients with myotonic dystrophy type 1
    Sedehizadeh, Saam
    Brook, J. David
    Maddison, Paul
    NEUROMUSCULAR DISORDERS, 2017, 27 (03) : 286 - 289
  • [9] Muscle MRI of the Upper Extremity in the Myotonic Dystrophy Type 1
    Hayashi, Kouji
    Hamano, Tadanori
    Kawamura, Yasutaka
    Kimura, Hirohiko
    Matsunaga, Akiko
    Lkawa, Masamichi
    Yamamura, Osamu
    Mutoh, Tatsuro
    Higuchi, Itsuro
    Kuriyama, Masaru
    Nakamoto, Yasunari
    EUROPEAN NEUROLOGY, 2016, 76 (1-2) : 87 - 94
  • [10] High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: A cross-sectional study
    Petri, Helle
    Witting, Nanna
    Ersboll, Mads Kristian
    Sajadieh, Ahmad
    Duno, Morten
    Helweg-Larsen, Susanne
    Vissing, John
    Kober, Lars
    Bundgaard, Henning
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 174 (01) : 31 - 36